Clinical Trials List
Protocol Number1403-0008
Completed
2022-05-01 - 2026-12-31
Phase II/III
Not yet recruiting1
Recruiting2
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Ta-Chung Chao Division of Radiation Therapy
- 吳宏達 Division of Radiation Therapy
- San-Chi Chen Division of Radiation Therapy
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Shih-Chiang Huang Division of Radiation Therapy
- 黃文冠 Division of Radiation Therapy
- 林宇旌 Division of Radiation Therapy
- Po-Jung Su Division of Radiation Therapy
- 張境夫 Division of Radiation Therapy
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
390 participants
